Table 2. Some potential risk sites found in the human genome.
Gene | Hits | Brief discription |
---|---|---|
Acyp2 | GGGGTTCCCCCTTGTTCTTGGGTCGGGATGCAGTCCAGGAACCCC | Acylphosphatase 2, muscle type |
Akr1b1 | GGGGTGCCCAGATTTTTCTCCCGAGTTCCAGACCCAGGGCACCCC | Aldo-ketoreductase family 1, member B1 |
Dusp4 | GGGGTTCCTTATCCTTCCCACCCGCCCTCAAACCCAGGAACCCC | Dual specificity phosphatase 4 |
Ptpn5 | GGGGTGCCCCCATGCGGCAAGGTCCGAGATGTGCCGGCACCCC | Protein tyrosine phosphatase, non-receptor |
Fli1 | GGGGTTCCTTTTACAGAGACAATTGTTGGGTCAAGAAGGAACCCC | Friend leukemia virus integration 1 |
Gpt2 | GGGGTTCCCTTGAACATGCGTAGGCTGGAACCCC | Glutamic pyruvate transaminase (alanine aminotransferase) |
Slc7a5 | GGGGTGCCTTGGGGGCAGTGCATTGGAGGAACCCC | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
Dhdh | GGGGTTCCAGGTAGAGGTTGAAAGGACCAAGGAACCCC | Dihydrodiol dehydrogenase (dimeric) |
Phf2 | CCCCAAGGAGCCCAGGACTTGGCCTTGGGG | PHD finger protein 2 |
Igf1r | CCCCAAGGAAAGCATATCATAAACAAGTTTTCCCTTGGGG | Insulin-like growth factor 1 receptor |
Wwp2 | CCCCAAGGGTACAGAACAGTGTCACCTTTGCCGTGGGG | WW domain containing E3 ubiquitin protein ligase 2 |
Flj39501 | CCCCAAGGTCACATTAATTGAGCGATCCGTGGGG | Cytochrome P450, family 2, subfamily E, polypeptide 2 homolog |
Plcb1 | CCCCAAGGCTCCATGTCTGAACATCATCACCTTGGGG | Phospholipase C, beta 1 (phosphoinositide -specific) |
Flj10945 | CCCCAAGGGCACACGTAGAAGCAGAGTTCCTTGGGG | Hypothetical protein FLJ10945 |
Stk11* | CCCCAGGGAGGCGGGGCTTTTGTGCAGAAATGTAGGGTTGGGG | This gene encodes a tumor suppressor |
Leng4 | CCCCAGTTGAGAAGCACTTGTCTAAACACTGGGG | This gene is malignant cell expression-enhanced gene/ |
Tumor progression -enhanced gene | ||
Cyp2b6 | CCCCACTATTTATTTTTGTAGAGATGTGTTTGGGG | Cytochrome P450, family 2, subfamily |
Ryr1 | CCCCAAGGTCCGGGTTGGGGACCTTGTGCTGGGG | Ryanodine receptor 1 (skeletal); Multi-process involved |
Icam1 | CCCCAGCCGAGAATTTCTCTTTGCGTCCTTCCTACTTTGGGG | Intercellular adhesion molecule 1 (CD54); Multi-process involved |
* Hit in STK11 has a relatively lower score but it has a similar motif to the wide type attPsites. So does the last four sites, LENG4, CYP2B6, RYR1, and ICAM1.